PhRMA member companies share how they are improving clinical trial diversity

As part of the biopharmaceutical industry ’sefforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our industry is developing potential best practices and key learnings that we are excited to share as part of our effort to tackle these challenges head on.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Health Equity Source Type: news